Delivery Order SPE2DB22D1106-SPE2DB25FFHX8
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $42,647.60 on August 14, 2025, for the supply of Herceptin 150 mg vials, with a completion date of September 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with the...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Herceptin 150 mg vials, valued at $10,114.52. This firm fixed-price delivery order was competitively awarded without set-asides on August 4, 2025, with an ultimate completion date of August 25, 2025. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Herceptin 150 mg vials, a monoclonal antibody used in cancer treatment. This firm fixed-price delivery order, valued at $2,670.42, represents a competitively awarded, non-set-aside contract with an ultimate completion date of August 18, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- This federal contract award, valued at $20,473.22, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4567529401 HERCEPTIN 150 MG VIALS, a specialty medication. The contract has an ultimate completion date of March 31, 2025 and is a firm fixed-price type. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,681.68 firm fixed-price contract is for the delivery of 4,567,615,883 units of Herceptin 150 mg vials. The contract has an ultimate completion date of April 8, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $26,605.30 to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Herceptin Hylecta 600mg injectable medication (10,000 5ml units). This firm fixed-price delivery order, which has no set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 16, 2025. The award represents a competitive procurement through the company's existing...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Herceptin 150 mg vials. The contract has a firm fixed price of $21,937.68 and an ultimate completion date of January 10, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,681.68, is for the delivery of HERCEPTIN 150 MG VIALS. There is no set-aside designation for this contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This prime...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,742.21 Firm Fixed Price Delivery Order contract is for the supply of HERCEPTIN 150 MG VIALS, a specialty oncology medication. The award is a child contract under a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical. This IDC...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the procurement of HERCEPTIN 150 MG VIALS. The contract has a ceiling value of $26,704.20 and is a firm fixed price delivery order with an ultimate completion date of April 29, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFHX8Delivery Order
The Defense Logistics Agency awarded a $21,363.36 delivery order to AmerisourceBergen Drug Corp for 150 mg Herceptin vials, with a completion date of September 30, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is performed at the contractor's facility in Conshohocken, Pennsylvania. Herceptin (trastuzumab) is a monoclonal antibody used in cancer treatment, particularly for HER2-positive breast cancer cases, making this a critical pharmaceutical supply for military and veteran healthcare systems. This delivery order operates as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply an extensive range of medications and medical supplies to support Defense Health Agency and military healthcare programs worldwide. AmerisourceBergen's substantial federal contract portfolio and demonstrated capability to meet rigorous procurement standards through open competition underscore its role as a major pharmaceutical distributor for federal medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.4k | 9/9/25 |